Abstract
Epstein-Barr virus latent membrane protein 1 (LMP1) activates NF-kappaB signaling pathways through two C-terminal regions, CTAR1 and CTAR2. Previous studies have demonstrated that BS69, a multidomain cellular protein, regulates LMP1/CTAR2-mediated NF-kappaB activation by interfering with the complex formation between TRADD and LMP1/CTAR2. Here, we found that BS69 directly interacted with the LMP1/CTAR1 domain and regulated LMP1/CTAR1-mediated NF-kappaB activation and subsequent IL-6 production. Regarding the mechanisms involved, we found that BS69 directly interacted with TRAF3, a negative regulator of NF-kappaB activation. Furthermore, small-interfering RNA-mediated knockdown experiments revealed that TRAF3 was involved in the BS69-mediated suppression of LMP1/CTAR1-induced NF-kappaB activation.
Copyright (c) 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Carrier Proteins / genetics
-
Carrier Proteins / metabolism*
-
Cell Cycle Proteins
-
Cell Line
-
Cell Line, Tumor
-
Co-Repressor Proteins
-
DNA-Binding Proteins
-
Humans
-
Immunoblotting
-
Immunoprecipitation
-
Interleukin-6 / metabolism
-
NF-kappa B / metabolism*
-
Polymerase Chain Reaction
-
Protein Binding
-
Protein Structure, Tertiary
-
RNA, Small Interfering
-
Reverse Transcriptase Polymerase Chain Reaction
-
Signal Transduction / genetics
-
Signal Transduction / physiology
-
TNF Receptor-Associated Factor 3 / genetics
-
TNF Receptor-Associated Factor 3 / metabolism*
-
Viral Matrix Proteins / genetics
-
Viral Matrix Proteins / metabolism*
Substances
-
Carrier Proteins
-
Cell Cycle Proteins
-
Co-Repressor Proteins
-
DNA-Binding Proteins
-
EBV-associated membrane antigen, Epstein-Barr virus
-
Interleukin-6
-
NF-kappa B
-
RNA, Small Interfering
-
TNF Receptor-Associated Factor 3
-
Viral Matrix Proteins
-
ZMYND11 protein, human